Official: Roche now owns Ventana Medical

March 2008
Inside Tucson Business;3/3/2008, Vol. 17 Issue 39, p3
The article reports that Roche Holdings has completed its 3.1 billion acquisition of Ventana Medical Systems Inc. through a short-form merger without a vote or meeting of Ventana's shareholders in Arizona. The author offers information about the terms and conditions of the acquisition. Possible economic benefits of the deal for both companies are also discussed.


Related Articles

  • Roche wins motion vs. Ventana, extends tender offer to Sept. 20. Pedersen, Amanda // Medical Device Daily;8/23/2007, Vol. 11 Issue 161, p1 

    The article reports that diagnostic company Roche of Basel, Switzerland has been granted a preliminary injunction from an Arizona district court enjoining Ventana Medical Systems of Tucson, Arizona from enforcing certain anti-takeover provisions related to the hostile takeover offer of Roche....

  • Ventura Medical buys building from biotech firm.  // Inside Tucson Business;11/24/2008, Vol. 18 Issue 25, p8 

    The article reports on the acquisition of the Oro Valley, Arizona facility of Integrated Biomolecule Corp. by Ventana Medical Systems for $6.5 million. The facility is an 18,000-square-foot building and Integrated Biomolecule is looking for new headquarters. Meanwhile, Ventana is owned by Roche...

  • At press time…Roche seeks $3 billion takeover of Ventana.  // Biomedical Business & Technology;Jul2007, Vol. 30 Issue 7, p27 

    The article reports on the bid of Basel, Switzerland-based Roche to acquire Ventana Medical Systems of Tucson, Arizona for about $3 billion. According to Roche, Ventana had declined to engage in discussions over the proposed takeover. The acquisition of Ventana is expected to help Roche expand...

  • Help Wanted. Arend, Mark // Site Selection;Sep/Oct2009, Vol. 54 Issue 5, p709 

    The article reports on the acquisition of Roche of the Ventana Medical Systems Inc. in February 2008 in Tucson, Arizona. It states that Ventana pioneered an automated method of cell staining for cancer testing and personalized treatment at the time of its acquisition. It adds that Ventana...

  • Roche wins in motion vs. Ventana, extends offer.  // Medical Technology & Devices Week;8/27/2007, Vol. 5 Issue 35, p4 

    This section reports on the preliminary injunction granted to Roche, enjoining with Ventana Medical Systems from enforcing anti-takeover provisions. Roche has been having problem generating interest for its tender offer on a $75-a-share takeover offer due to its refusal to raise its offering...

  • Finally! Roche's sweetened offer of $3 billion will satisfy Ventana. Pedersen, Amanda // Diagnostics & Imaging Week;1/24/2008, Vol. 11 Issue 4, p1 

    The article reports on the merger agreement of Ventana Medical Systems with Roche. Roche offers $89.50 a share, which make the deal valued at $3.4 billion. In November 2007, a confidentiality agreement was entered by the companies, which allowed Roched to begin due diligence and have access to...

  • Ventana Medical says 'no' to hostile takeover effort.  // Inside Tucson Business;7/16/2007, Vol. 17 Issue 5, p3 

    The article reports on the rejection made by Ventana Medical Systems on the takeover offer of Roche in Arizona. The board of directors of Ventana Medical Systems have unanimously voted for the rejection of the hostile takeover offer of Roche and it has also recommended that the shareholders of...

  • Hologic completes BioLucent buy; Roche again extends Ventana offer.  // Medical Device Daily;9/21/2007, Vol. 11 Issue 181, p1 

    The article offers news briefs on deals in the U.S. medical device industry as of September 21, 2007. Diagnostic imaging systems company Hologic has completed the acquisition of women's health company BioLucent for about $70 million in cash and stock. Roche Holding commences a tender offer to...

  • Frustrated Roche goes public with hostile takeover of Ventana Medical Systems. Hatfield, David // Inside Tucson Business;7/2/2007, Vol. 17 Issue 3, p4 

    The article reports on the decision of Roche Group company to go public with a $3 billion hostile takeover of Ventana Medical Systems Inc. in Basel, Switzerland. On June 25, 2007, a $75 per share was offered to the public which represents 55 percent premium over Ventana's three-month average...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics